Stijn Kelchtermans
banner
kingofthebongo.bsky.social
Stijn Kelchtermans
@kingofthebongo.bsky.social
Professor of strategy and innovation, KU Leuven
https://www.kuleuven.be/wieiswie/en/person/00016281
@kuleuvenuniversity.bsky.social celebrates its 600 years anniversary. I enjoyed my visit of the nanocentre and Thomas Hertog's 600-second Einstein telecope lecture. Here's my own talk, even more concise (60 seconds!). Thanks to Skapa Media for putting camera-shy academics at ease! :) t.ly/IUFAO
February 17, 2025 at 7:59 AM
Policy coordination is essential, but how can we measure and improve it effectively? Our latest paper (w/ A. Santos), published in Science and Public Policy, introduces a method that integrates expert assessment with automated content analysis. #PolicyCoordination #SemanticAnalysis tiny.cc/azeyzz
December 1, 2024 at 6:06 PM
Thanks to POM for inviting me to deliver the #keynote for the #CrossS3 #Interreg France-Wallonie-Vlaanderen launch event. Great projects and high-quality teams!
November 26, 2024 at 2:12 PM
📢 #Conference announcement. Great venue to present & discuss the #economics of #science (broadly defined)! Submit your work for the 18th Workshop on the Organisation, Economics and Policy of Scientific Research (#WOEPS), 3-4 April 2025, #Strasbourg. Submit by 6 Jan 2025. More info: tiny.cc/sg3vzz
November 14, 2024 at 8:53 AM
KU Leuven, in collaboration with Google, EPO, USPTO, UCD Dublin, and EPFL, invites you to the 9th Annual Summer School on Data and Algorithms for Science, Technology & Innovation (ST&I) Studies, 13-14 Sep, campus Opera in Antwerp. Submission DL: 15 June. More info: feb.kuleuven.be/drc/MSI/sti
June 5, 2024 at 1:20 PM
Using text-based indicators in strategic management research is like, ehm..., bungee jumping! Better check whether the elastic cord is reliable. :) New paper in Strategic Organization. #exploration #exploitation #ambidexterity #contentanalysis #firmperformance shorturl.at/hKQY1
February 20, 2024 at 7:47 AM
Nieuw Leuven Economisch Standpunt: 1) #farmabedrijven nemen gepatenteerde kandidaat-geneesmiddelen met sterkere wortels in wetenschappelijk #onderzoek gemakkelijker op in klinische studies, 2) nog meer als ze zélf het onderzoek deden, dus *R* en *D* “onder één dak”. shorturl.at/tFHP3
February 8, 2024 at 12:03 PM